Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC

NCT02436772 · clinicaltrials.gov ↗
COMPLETED
Status
74
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

SCRI Development Innovations, LLC